Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor‐Positive/Human Epidermal Growth Factor Receptor 2‐Negative ( HR +/ HER2 −) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study

Documenti analoghi

• Exposure‐Response Analyses of Datopotamab Deruxtecan (Dato‐DXd) in Patients with Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2)‐Negative Breast Cancer
  di: Zoey Tang, et al.
  Pubblicazione: (2026)
• Hypogymnia irregularis (Ascomycota: Parmeliaceae)—a new species from Asia
  di: McCune, Bruce
  Pubblicazione: (2011)
• Single Transferable Vote and Paradoxes of Negative and Positive Involvement
  di: McCune, David
  Pubblicazione: (2024)
• Analysis of ecological communities : PC-ORD multivariate analysis of ecological data; version 5 user´s booklet [Recurso electrónico] / Bruce McCune, M. J. Mefford
  di: McCune, Bruce
• Os Mediadores Pedagógicos e a Territorialização da Agroecologia
  di: Nils McCune
  Pubblicazione: (2017)